Sergei Gryaznov insider trades
Open-market stock purchases and sales by Sergei Gryaznov, Chief Scientific Officer at MAIA Biotechnology, Inc, from SEC Form 4 filings since Aug 1, 2022.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -47%.
Companies traded
- MAIA MAIA Biotechnology, Inc: 2 buys, last Jun 1, 2026